Are you attending the European Society of Gene and Cell Therapy Annual Congress? Let’s connect! Our team will be on-site presenting 7 different posters and is looking forward to exchanging information about the latest updates in #GeneTherapy! Learn more: https://lnkd.in/efye-f8c #ESGCT2024
AviadoBio
Biotechnology Research
London, England 11,662 followers
A revolution in gene therapy for neurodegenerative disorders.
About us
At AviadoBio, we are relentlessly chasing cures by translating groundbreaking science and precision delivery into life-changing medicines for people living with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). With our deep understanding of the brain and our suite of proprietary gene therapy platforms and delivery technologies, we are working relentlessly to overcome the challenges of delivering the right drug to the right place. Our innovative, neuroanatomy-led approach is designed to maximize the therapeutic potential of gene therapy to halt or potentially reverse neurodegenerative diseases. The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.
- Website
-
http://www.aviadobio.com
External link for AviadoBio
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
Get directions
20 Water Street
London, England E14 9GG, GB
Employees at AviadoBio
Updates
-
We’re thrilled to announce with Astellas Pharma, an exclusive option and license agreement for AVB-101, an investigational, AAV-based #GeneTherapy in Phase 1/2 development for patients with #FrontotemporalDementia with progranulin mutations (FTD-GRN). Learn more: https://lnkd.in/e3CrzXPN #biotech
-
-
Our CEO, Lisa Deschamps will be presenting at this year’s Alliance for Regenerative Medicine’s Meeting on the Mesa! Before the presentation, learn more about #AviadoBio and our #GeneTherapy pipeline: www.aviadobio.com #CGMesa24
-
-
Don’t miss this BIA webinar tomorrow (1st October) on Attracting Next Generation Talent for SMEs. Our Senior Director of People, John Lavarino, Assoc (CIPD) will be taking part in the discussion.
Join us on the 📅 1 October 📍for a webinar on Attracting Next Generation Talent for SMEs ➡ https://lnkd.in/e3rKvSDY With skills shortages across all sectors, the webinar will include discussions on the need to ensure we attract talent from the broadest #TalentPool. We look forward to insights from 👇 📌 Kate Barclay, Skills Strategy Consultant, BioIndustry Association (BIA) 📌 Ian Cooper, National Head of Business Development, Speakers for Schools 📌 John Lavarino, Assoc (CIPD), Senior Director of People, AviadoBio 📌 Ajay Sharman National Lead, STEM Learning UK 📌 Stephen Stewart, Head of Skills, Cell and Gene Therapy Catapult 📌 Ivan Wall, Co-Director, Resilience
-
“Frontotemporal dementia has no known therapeutic answers and so there is a need to continue to pursue the science.” To close out #WorldFTDAwarenessWeek, Dr. Brad Elder from The Ohio State University Wexner Medical Center shares his perspective on the urgent need for more research in #FTD. We're in this together. #endFTD #FrontotemporalDementia
-
Katie Brandt, a #dementia care expert, advocate, and educator shares a few words on the importance of raising awareness of #FrontotemporalDementia and what you can do to support. We're in this together. #endFTD #WorldFTDAwarenessWeek #GeneTherapy
-
#DYK: Granulin (GRN) is one of the three main genes that account for genetic #FrontotemporalDementia? Dr. Brad Elder from The Ohio State University Wexner Medical Center discusses what a GRN mutation means and how it affects people with FTD. We're in this together. #endFTD #WorldFTDAwarenessWeek #FrontotemporalDementia #GeneTherapy
-
Dementia care expert, advocate, and educator Katie Brandt highlights some of the major misconceptions associated with #FrontotemporalDementia, including the symptoms of the disease like behavioral and personality changes that are often overlooked. We’re in this together. #endFTD #WorldFTDAwarenessWeek #FTD
-
Do you know what frontotemporal dementia is? To kick-off World FTD Awareness Week Brad Elder of The Ohio State University Wexner Medical Center sheds light on the devastating disease and how it affects patients. We’re in this together. #endFTD #FrontotemporalDementia #WorldFTDAwarenessWeek #FTDAwarenessWeek
-
#ICYMI: Our clinical team presented early experiences from our Phase 1/2 ASPIRE-FTD trial of investigational #GeneTherapy in people with #FrontotemporalDementia with GRN mutations, at the 2024 International Society for Frontotemporal Dementia (ISFTD) conference. Learn more: https://lnkd.in/dscTMjpU #ISFTD2024 #FTD #endFTD
-